Research articles
ScienceAsia 48 (2022): 32-36 |doi:
10.2306/scienceasia1513-1874.2022.007
Effects of octacosanol on HMG-CoA reductase and
cyclooxygenase-2 activities in the HT-29 human colorectal
cancer cell line
Suphaket Saenthaweesuka, Atcharaporn Thaeomorb, Pornrut Rabintossaporna, Jarinyaporn Naowaboota, Nuntiya Somparna,*
ABSTRACT: Octacosanol (OCT) is a major component of policosanol which has been reported to possess anti-inflammatory and lipid-lowering effects. Therefore, it was our interest to evaluate the effects of OCT on HMG-CoA reductase (HMGR) and cyclooxygenase-2 (COX-2) activities in a human colorectal cancer cell line (HT-29). Our results demonstrate that 100 µM OCT decreased viability of HT-29 cells as analyzed by sulforhodamine B colorimetric assay with more pronounced effects seen in cells treated with atorvastatin (AST) or celecoxib (CLX), the inhibitors to HMGR and COX-2, respectively. Additionally, the activity of HMGR was found to be inhibited in cells treated with OCT, while COX-2 activity was unaffected; these effects were also more pronounced in AST- and CLX-treated cells. In cells treated with OCT, a significant decrease in HMGR protein expression was observed, but there was no alteration in COX-2 protein expression as determined by Western blot. Taken together, our results show that OCT inhibited HT-29 cell growth and that this effect might be attributed to the reduction of HMGR protein expression and activity.
Download PDF
56 Downloads 575 Views
| a |
Preclinical Science, Faculty of Medicine, Thammasat University 12120 Thailand |
| b |
School of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000 Thailand |
* Corresponding author, E-mail: nuntiya_tom@hotmail.com
Received 24 Mar 2021, Accepted 22 Jul 2021
|
